# Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX

> **NCT02517671** · NA · WITHDRAWN · sponsor: **David Grant U.S. Air Force Medical Center**

## Conditions studied

- Cardiovascular Disease
- Pulmonary Disease

## Interventions

- **DEVICE:** Enhanced External Counterpulsation (EECP)

## Key facts

- **NCT ID:** NCT02517671
- **Lead sponsor:** David Grant U.S. Air Force Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-01
- **Primary completion:** 2017-10-07
- **Final completion:** 2017-10-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI failed to file continuation report.
- **Last updated:** 2018-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517671, "Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02517671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*